Recent performance snapshot
MetLife (MET) has drawn attention after a recent stretch of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, year to date, and past year.
At a last close of $67.97 and annual revenue of about $77.1b against net income of roughly $3.2b, investors are weighing how this large US insurer’s fundamentals line up with the recent pullback.
See our latest analysis for MetLife.
MetLife’s recent 1 day share price return of 1.19% and 7 day return of 5.37% extend a run of weaker momentum, with a 30 day share price return of 12.08% and year to date share price return of 15.38%. This is occurring even though the 3 year total shareholder return sits at 35.93% and the 5 year total shareholder return is 29.08%, suggesting the latest pullback reflects more of a shift in sentiment than the longer term record.
If this insurance move has you thinking about where capital may be treated differently, it could be worth scanning other areas of the market such as 19 top founder-led companies to see what stands out.
So with MetLife trading around $67.97 after a period of weaker returns, but carrying annual revenue of about $77.1b and net income near $3.2b, is this pullback mispricing the insurer, or is the market already factoring in its future growth?
Most Popular Narrative: 25.3% Undervalued
MetLife’s most followed narrative pegs fair value at about $90.93, well above the recent $67.97 close, and builds that view from detailed growth, margin, and discount rate assumptions.
Strong, sustained premium and sales growth in high-potential international markets (Asia, Latin America, EMEA) positions MetLife to capitalize on growing middle-class wealth and increased insurance penetration, supporting long-term revenue and top-line growth.
Ongoing investment in digital transformation (AI-driven underwriting, process automation, embedded insurance partnerships, and tech-enabled distribution) enables MetLife to reduce acquisition and operating costs, improve customer engagement and retention, and, over time, boost net margins.
Want to see what kind of revenue path and profit margins are assumed to back that $90 plus fair value, and how buybacks feed into the earnings math? The full narrative lays out the growth rates, margin shifts, and valuation multiple the market would need to accept for MetLife to reach that mark.
Result: Fair Value of $90.93 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on investment returns and credit quality holding up, as persistent low yields or commercial mortgage loan losses could quickly challenge that upside story.
Find out about the key risks to this MetLife narrative.
Next Steps
If this mix of potential upside and clear risks leaves you undecided, take a closer look now and weigh 4 key rewards and 2 important warning signs for yourself.
Looking for more investment ideas?
If you stop with just one stock, you risk missing other opportunities that could suit your goals better, so widen your search before you commit.
- Target income potential with a focus on stability by reviewing our list of 14 dividend fortresses that may suit a more cash flow oriented portfolio.
- Zero in on quality at a reasonable price by checking companies in our 48 high quality undervalued stocks that pair solid fundamentals with attractive valuations.
- Prioritise resilience by scanning 68 resilient stocks with low risk scores where balance sheets and risk metrics help you keep downside firmly in view.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com